Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient

被引:6
|
作者
Niscola, Pasquale [1 ,5 ]
Mazzone, Carla [1 ]
Fratoni, Stefano [2 ]
Ardu, Nicolina Rita [1 ]
Cesini, Laura [1 ]
Giovannini, Marco [1 ]
Ottone, Tiziana [4 ]
Anemona, Lucia [3 ]
Voso, Maria Teresa [4 ]
de Fabritiis, Paolo [1 ]
机构
[1] ASL Roma 2, S Eugenio Hosp, Hematol Unit, Rome, Italy
[2] ASL Roma 2, S Eugenio Hosp, Pathol Dept, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy
[5] S Eugenio Hosp, Hematol Unit, Piazzale Umanesimo 10, I-00144 Rome, Italy
关键词
Acute myeloid leukemia; Leukemia cutis; Nucleophosmin-1; Venetoclax; azacitidine; VENETOCLAX;
D O I
10.1159/000531101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of acute myeloid leukemia with NPM1 mutation and disseminated leukemia cutis in a very old patient, who achieved a long-lasting response to the azacitidine/venetoclax combination with molecular complete remission, given the potential value of this rarely observed clinical outcome.
引用
收藏
页码:408 / 412
页数:5
相关论文
共 50 条
  • [1] NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features
    Luskin, Marlise R.
    Huen, Auris O.
    Brooks, Sarah A.
    Stewart, Campbell
    Watt, Christopher D.
    Morrissette, Jennifer J. D.
    Lieberman, David B.
    Bagg, Adam
    Rosenbach, Misha
    Perl, Alexander E.
    HAEMATOLOGICA, 2015, 100 (10) : E412 - E414
  • [2] Leukemia Cutis in a Patient with Acute Myeloid Leukemia Undergoing Azacitidine-Venetoclax: Case Presentation and Review of the Literature
    Buzzatti, Elisa
    Mauro, Cristina
    Botti, Caterina
    Presicci, Roberta
    Paterno, Giovangiacinto
    Palmieri, Raffaele
    Gurnari, Carmelo
    Mallegni, Flavia
    Meddi, Elisa
    Moretti, Federico
    Cardillo, Lucia
    Mezzanotte, Valeria
    Taka, Kristian
    De Marchi, Lucrezia
    Maurillo, Luca
    Buccisano, Francesco
    Venditti, Adriano
    del Principe, Maria Ilaria
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2025, 17 (01)
  • [3] Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
    Castano-Diez, Sandra
    Alamo, Jose Ramon
    Lopez-Guerra, Monica
    Gomez-Hernando, Marta
    Zugasti, Ines
    Jimenez-Vicente, Carlos
    Guijarro, Francesca
    Lopez-Oreja, Irene
    Esteban, Daniel
    Charry, Paola
    Torrecillas, Victor
    Mont-de Torres, Lucia
    Cortes-Bullich, Albert
    Bataller, Alex
    Guardia, Ares
    Munarriz, Daniel
    Carcelero, Esther
    Riu, Gisela
    Triguero, Ana
    Tovar, Natalia
    Vela, Dolors
    Bea, Silvia
    Costa, Dolors
    Colomer, Dolors
    Rozman, Maria
    Esteve, Jordi
    Diaz-Beya, Marina
    ONCOLOGIST, 2024,
  • [4] Benefit of the Reduced Dose Combination of Azacitidine and Venetoclax in an Elderly Patient With Acute Myeloid Leukemia
    Fujino, Keita
    Ureshino, Hiroshi
    Yoshida, Tetsumi
    Ichinohe, Tatsuo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [5] NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents
    Prata, Pedro Henrique
    Bally, Cecile
    Prebet, Thomas
    Recher, Christian
    Venton, Geoffroy
    Thomas, Xavier
    Raffoux, Emmanuel
    Pigneux, Arnaud
    Cluzeau, Thomas
    Desoutter, Judith
    Gay, Julie
    Preudhomme, Claude
    Fenaux, Pierre
    Ades, Lionel
    HAEMATOLOGICA, 2018, 103 (10) : E455 - E457
  • [6] Durable remission of acute myeloid leukemia in an elderly patient following a limited course of azacitidine and venetoclax
    Ehsan, Hamid
    Iqbal, Qamar
    Masood, Adeel
    Grunwald, Michael R.
    LEUKEMIA RESEARCH REPORTS, 2022, 18
  • [7] Identification of a novel NPM1 mutation in acute myeloid leukemia
    Yao, Yiyi
    Lin, Xiangjie
    Wang, Chen
    Gu, Ying
    Jin, Jie
    Zhu, Yinghui
    Wang, Huafeng
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [8] Identification of a novel NPM1 mutation in acute myeloid leukemia
    Yiyi Yao
    Xiangjie Lin
    Chen Wang
    Ying Gu
    Jie Jin
    Yinghui Zhu
    Huafeng Wang
    Experimental Hematology & Oncology, 12
  • [9] Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study
    Oren Pasvolsky
    Shai Shimony
    Ron Ram
    Avichai Shimoni
    Liat Shargian
    Batia Avni
    Ofir Wolach
    Tzippy Shochat
    Ronit Yerushalmi
    Odelia Amit
    Pia Raanani
    Moshe Yeshurun
    Annals of Hematology, 2022, 101 : 379 - 387
  • [10] Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study
    Pasvolsky, Oren
    Shimony, Shai
    Ram, Ron
    Shimoni, Avichai
    Shargian, Liat
    Avni, Batia
    Wolach, Ofir
    Shochat, Tzippy
    Yerushalmi, Ronit
    Amit, Odelia
    Raanani, Pia
    Yeshurun, Moshe
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 379 - 387